Is It Safe (and When) to Stop Oral Anticoagulation After Ablation for Atrial fibrillation? (Do We Have Enough Evidence to Solve the Dilemma?)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is It Safe (and When) to Stop Oral Anticoagulation After Ablation for Atrial fibrillation? (Do We Have Enough Evidence to Solve the Dilemma?)
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-07
DOI
10.1007/s10557-021-07246-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
- (2021) Salim S. Virani et al. CIRCULATION
- Generalizability of the CASTLE-AF Trial: Catheter Ablation for Patients with Atrial Fibrillation and Heart Failure in Routine Practice
- (2020) Peter A. Noseworthy et al. HEART RHYTHM
- Interrupted or Uninterrupted Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation
- (2020) Pingping Yang et al. CARDIOVASCULAR DRUGS AND THERAPY
- Long-term effectiveness of catheter ablation in patients with atrial fibrillation and heart failure
- (2020) Michelle Samuel et al. EUROPACE
- Can Anticoagulation Be Stopped After Ablation of Atrial Fibrillation?
- (2020) Jackson J. Liang et al. Current Cardiology Reports
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Uninterrupted or Minimally Interrupted Direct Oral Anticoagulant Therapy is a Safe Alternative to Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Meta-Analysis
- (2020) Máté Ottóffy et al. Journal of Clinical Medicine
- Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients
- (2019) Tze-Fan Chao et al. THROMBOSIS AND HAEMOSTASIS
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation
- (2019) Douglas L. Packer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. HEART RHYTHM
- Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
- (2019) Stefan H Hohnloser et al. EUROPEAN HEART JOURNAL
- Idiopathic atrial fibrillation patients rapidly outgrow their low thromboembolic risk: a 10-year follow-up study
- (2019) B. Weijs et al. Netherlands Heart Journal
- Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta‐analysis
- (2019) Jorge Romero et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score
- (2019) Rachel M. Kaplan et al. CIRCULATION
- Catheter Ablation Versus Medical Therapy for Atrial Fibrillation
- (2019) Zain Ul Abideen Asad et al. Circulation-Arrhythmia and Electrophysiology
- The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study
- (2019) Wang-Yang Yang et al. EUROPACE
- Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation
- (2019) James V. Freeman et al. Circulation-Arrhythmia and Electrophysiology
- Screening for atrial fibrillation: a call for evidence
- (2019) Nicholas R Jones et al. EUROPEAN HEART JOURNAL
- The Emerging Role of Wearable Technologies in Arrhythmia Detection
- (2018) Christopher C. Cheung et al. CANADIAN JOURNAL OF CARDIOLOGY
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
- (2018) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation
- (2018) Rhanderson Cardoso et al. HEART RHYTHM
- Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis
- (2018) Sérgio Barra et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A meta-analysis of randomized controlled trials of uninterrupted periprocedural anticoagulation strategy in patients undergoing atrial fibrillation catheter ablation
- (2018) Yating Zhao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation
- (2018) Jackson J. Liang et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis
- (2018) Natale Daniele Brunetti et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Catheter Ablation for Atrial Fibrillation with Heart Failure
- (2018) Nassir F. Marrouche et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incident Risk Factors and Major Bleeding in Patients with Atrial Fibrillation Treated with Oral Anticoagulants: A Comparison of Baseline, Follow-up and Delta HAS-BLED Scores with an Approach Focused on Modifiable Bleeding Risk Factors
- (2018) Tze-Fan Chao et al. THROMBOSIS AND HAEMOSTASIS
- Association of Burden of Atrial Fibrillation With Risk of Ischemic Stroke in Adults With Paroxysmal Atrial Fibrillation
- (2018) Alan S. Go et al. JAMA Cardiology
- Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis
- (2018) Riccardo Proietti et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review
- (2018) Ethan Borre et al. THROMBOSIS AND HAEMOSTASIS
- Complications of pulmonary vein isolation in atrial fibrillation: predictors and comparison between four different ablation techniques: Results from the MIddelheim PVI-registry
- (2017) Yves De Greef et al. EUROPACE
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
- (2017) Hugh Calkins et al. EUROPACE
- Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry
- (2017) Elena Arbelo et al. EUROPEAN HEART JOURNAL
- Thromboembolic and bleeding risks in patients undergoing atrial fibrillation ablation: oral anticoagulation perspectives
- (2017) David F. Briceño et al. Expert Opinion On Drug Safety
- New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interrupted or continuous warfarin
- (2017) Yue Zhao et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction
- (2017) Sandeep Prabhu et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
- (2017) Hugh Calkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation
- (2017) Sara Själander et al. JAMA Cardiology
- Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted DeviceCLINICAL PERSPECTIVE
- (2016) Luigi Di Biase et al. CIRCULATION
- The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis
- (2016) Anand N. Ganesan et al. EUROPEAN HEART JOURNAL
- Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study
- (2016) TAISHI KUWAHARA et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Long-term events following atrial fibrillation rate control or transcatheter ablation
- (2016) Cristina Gallo et al. Journal of Cardiovascular Medicine
- Stroke and thromboembolic event rates in atrial fibrillation according to different guideline treatment thresholds: A nationwide cohort study
- (2016) Peter Brønnum Nielsen et al. Scientific Reports
- Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA)
- (2015) T. S. Potpara et al. EUROPACE
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Changes in Renal Function in Patients With Atrial Fibrillation
- (2015) Michael Böhm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation–Related Stroke
- (2015) Derek T. Hayden et al. STROKE
- Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
- (2015) Peter A. Noseworthy et al. Journal of the American Heart Association
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Oral anticoagulation is frequently discontinued after ablation of paroxysmal atrial fibrillation despite previous stroke: data from the German Ablation Registry
- (2014) Jana Mareike Nührich et al. Clinical Research in Cardiology
- Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation
- (2014) R. Providencia et al. EUROPACE
- Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
- (2014) R. A. Winkle et al. EUROPACE
- Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark
- (2014) Deniz Karasoy et al. EUROPEAN HEART JOURNAL
- Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications
- (2014) Ilpo Nuotio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of Stroke or Transient Ischemic Attack After Atrial Fibrillation Ablation with Oral Anticoagulant Use Guided by ECG Monitoring and Pulse Assessment
- (2014) MICHAEL P. RILEY et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
- (2014) A. J. Wagstaff et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature
- (2013) Stefan H. Hohnloser et al. EUROPACE
- Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes
- (2013) Roger A. Winkle et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
- (2013) Raffaele Caterina et al. THROMBOSIS AND HAEMOSTASIS
- Anticoagulation Management Pre- and Post Atrial Fibrillation Ablation: A Survey of Canadian Centres
- (2012) Vartan Mardigyan et al. CANADIAN JOURNAL OF CARDIOLOGY
- Ablation of Atrial Fibrillation Under Therapeutic Warfarin Reduces Periprocedural Complications
- (2012) Pasquale Santangeli et al. Circulation-Arrhythmia and Electrophysiology
- Relationship between the CHADS2 score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation
- (2012) Tze-Fan Chao et al. HEART RHYTHM
- Subclinical Atrial Fibrillation and the Risk of Stroke
- (2012) Jeff S. Healey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discerning the Incidence of Symptomatic and Asymptomatic Episodes of Atrial Fibrillation Before and After Catheter Ablation (DISCERN AF)
- (2012) Atul Verma et al. JAMA Internal Medicine
- Incidence of Late Thromboembolic Events After Catheter Ablation of Atrial Fibrillation
- (2011) Atsuhiko Yagishita et al. CIRCULATION JOURNAL
- Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of TRENDS
- (2011) Emile G. Daoud et al. HEART RHYTHM
- The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation
- (2010) Sakis Themistoclakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk
- (2009) Taya V. Glotzer et al. Circulation-Arrhythmia and Electrophysiology
- Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
- (2009) Riccardo Cappato et al. Circulation-Arrhythmia and Electrophysiology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started